3.5.3.18	adiponectin	-	697831	
3.5.3.18	all-trans retinoic acid	inhibits cobalt chloride induced inhibition of DDAH	699684	
3.5.3.18	all-trans-retinoic acid	1.9fold increase in DDAH-2 mRNA and protein expression	697831	
3.5.3.18	aminoguanidine	-	697831	
3.5.3.18	aspirin	-	697831	
3.5.3.18	D-histidine	activating ability in decreasing order: histamine, imidazole, L-histidine, D-histidine	652188	
3.5.3.18	EDTA	-	697831	
3.5.3.18	epigallocatechin gallate	-	697831	
3.5.3.18	fenofibrate	-	697831	
3.5.3.18	histamine	activating ability in decreasing order: histamine, imidazole, L-histidine, D-histidine	652188	
3.5.3.18	imidazole	activating ability in decreasing order: histamine, imidazole, L-histidine, D-histidine	652188	
3.5.3.18	Insulin	-	697831	
3.5.3.18	interleukin-1beta	-	697831	
3.5.3.18	interleukin-1beta	2fold increase in DDAH-1 protein expression	697831	
3.5.3.18	L-histidine	activating ability in decreasing order: histamine, imidazole, L-histidine, D-histidine	652188	
3.5.3.18	losartan	-	697831	
3.5.3.18	additional information	increase of DDAH-2 mRNA and protein level induced by SNAP, NOR, 8-bromo-cGMP or CNP	698209	
3.5.3.18	additional information	mRNA expression levels of DDAH-I are not changed in pioglitazone-treated rats	668890	
3.5.3.18	additional information	probucol and the intracellular antioxidant pyrrolidine dithiocarbamate significantly attenuate inhibition of endothelial DDAH activity by oxidized-low density lipoprotein or lysophosphatidylcholine, but probucol or PDTC itself had no effect on the activity of DDAH	668175	
3.5.3.18	additional information	type of buffer dramatically influences enzyme activity, activity in imidazole/HCl buffer is about 25% higher than in phosphate buffer	652188	
3.5.3.18	nebivolol	2fold increase in DDAH-2 mRNA and protein expression	697831	
3.5.3.18	oestradiol	60-70% increase in DDAH-2 mRNA and protein expression	697831	
3.5.3.18	pioglitazone	2-3fold increase of DDAH-2 mRNA and protein levels	697831	
3.5.3.18	pravastatin	-	697831	
3.5.3.18	probucol	-	697831	
3.5.3.18	SNAP	increase of DDAH-2 mRNA and protein level, time and concentration dependent	698209	
3.5.3.18	taurin	-	697831	
3.5.3.18	taurine	-	697831	
3.5.3.18	telmisartan	-	697831	
3.5.3.18	visfatin	mRNA and protein expression of DDAH2 upregulated after 24 h stimulation of visfatin	697549	
3.5.3.18	vitamin E	-	697831	
3.5.3.18	xanthone	-	697831